Stocks
IDEAYA Biosciences, Inc.IDYA
NASDAQHealthcareBiotechnology$34.71
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted oncology therapies, including a lead asset in Phase 2/3 trials for a specific genetic mutation-driven tumor type. Its pipeline focuses on synthetic lethality and immuno-oncology combinations, and investors track it for its potential in precision medicine and upcoming clinical data readouts.
52W Range: $26.81-$42.68
Congressional Interest in IDEAYA Biosciences, Inc. (IDYA)
No congressional trades have been disclosed for IDEAYA Biosciences, Inc. (IDYA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IDYA?
No congressional trades found for this stock.